logo
Plus   Neg
Share
Email

Rolls-Royce Names Panos Kakoullis CFO And Executive Director, Effective May 3

Rolls-Royce Holdings plc. (RYCEF.PK,RR.L,RYCEY.PK) announced Monday the appointment of Panos Kakoullis as Chief Financial Officer and Executive Director, succeeding Stephen Daintith who is leaving the company as announced last year.

Daintith will leave Rolls-Royce on March 19, shortly after the publication of the Group's full year 2020 results, while Kakoullis will take up his new role on May 3.

To support the company in the period of transition, Ben Fidler, who is currently acting as Deputy CFO and joined the Executive Team effective January 1, will be appointed as Interim CFO.

Fidler, who joined Rolls-Royce in 2017 from Deutsche Bank, will continue to carry out his current responsibilities as Vice President of Business Performance in addition to his new role.

The new CFO Kakoullis more recently joined PA Consulting. He started his career at Deloitte, and was, until May 2019, Global Head of Deloitte's Audit and Assurance Practice.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Credit Suisse Group AG were losing around 6 percent in Swiss trading after the banking major slipped to a loss in its first quarter from a profit last year on hefty charge related to a US-based hedge fund. Net revenues, however, were significantly higher. Looking ahead, the company expects market volumes to return to lower, and more normal, levels in the coming quarters. Metal Ware Corp. is recalling about 5,350 units of NESCO coffee bean roasters citing fire risk, the U.S. Consumer Product Safety Commission said in a statement. The recall involves Model CR-04-13 Coffee Bean Roasters with a date code of 2520 or 3220 printed at the bottom right of the ETL Intertek label on the product and on the box. Pfizer has uncovered the counterfeit versions of its Covid-19 vaccine in Mexico and Poland, according to a Wall Street Journal report. The vaccine was developed in partnership with Germany's BioNTech SE. Though there have been several reports of counterfeit versions of the Covid-19 vaccine, this seems to be the first confirmed instance.
Follow RTT